HomeBLAB • CNSX
add
Britannia Life Sciences Inc
Previous close
$0.070
Day range
$0.060 - $0.065
Year range
$0.030 - $0.13
Market cap
9.74M CAD
Avg Volume
20.83K
P/E ratio
5.71
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.81M | 9.57% |
Operating expense | 1.17M | 35.58% |
Net income | 535.32K | 1,085.11% |
Net profit margin | 29.56 | 998.48% |
Earnings per share | — | — |
EBITDA | 68.77K | -83.79% |
Effective tax rate | 13.14% | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.72M | -29.67% |
Total assets | 22.96M | -0.02% |
Total liabilities | 11.06M | -17.59% |
Total equity | 11.90M | — |
Shares outstanding | 162.25M | — |
Price to book | 1.40 | — |
Return on assets | 0.35% | — |
Return on capital | 0.42% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 535.32K | 1,085.11% |
Cash from operations | 576.00K | -12.82% |
Cash from investing | -952.64K | -1,047.66% |
Cash from financing | -481.48K | -97.83% |
Net change in cash | -804.11K | -271.40% |
Free cash flow | 836.24K | 229.21% |
About
Founded
2000
Headquarters
Website
Employees
28